Compare
Viking Global Technologies, Inc. vs Arcadia Biosciences, Inc. vs Evolution Petroleum Corp vs Trio Petroleum Corp
| Latest fiscal year | Viking Global Technologies, Inc. VGTK | Arcadia Biosciences, Inc. RKDA | Evolution Petroleum Corp EPM | Trio Petroleum Corp TPET |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-06-30 | 2025-10-31 |
| Revenue | $6.23M | $4.86M | $86.34M | $398.7K |
| Revenue growth (YoY) | -78.2% | -3.7% | +0.6% | +87.0% |
| Gross margin | 25.4% (computed) | 36.2% (computed) | 41.7% (computed) | 55.9% |
| Operating margin | -127.6% | -51.5% | 4.0% | n/m |
| Net margin | -70.8% | -48.1% | -2.8% | n/m |
| Net income | -$4.41M | -$2.34M | -$2.43M | -$7.28M |
| EPS (Diluted) | -$0.02 | -$1.71 | -$0.08 | -$0.80 |
| Operating cash flow | -$2.33M | -$4.74M | $23.52M | -$2.60M |
| Free cash flow | -$2.34M | -$4.74M | n/a | n/a |
| Cash & equivalents | n/a | $259.0K | $6.14M | n/a |
| Total assets | $19.84M | $6.55M | $168.70M | $13.21M |
| Total liabilities | $63.21M | $2.41M | $108.29M | $1.91M |
| Shareholders' equity | -$49.77M | $4.14M | $60.40M | $11.30M |
| Return on year-end equity | n/a | -56.5% | -4.0% | -64.4% |
| Shares outstanding | 281.69M | 1.37M | 35.95M | 9.05M |
Revenue, most recent five fiscal years
| Fiscal year | Viking Global Technologies, Inc. | Arcadia Biosciences, Inc. | Evolution Petroleum Corp | Trio Petroleum Corp |
|---|---|---|---|---|
| Latest | $6.23M Ended 2025-12-31 | $4.86M Ended 2025-12-31 | $86.34M Ended 2026-06-30 | $398.7K Ended 2025-10-31 |
| 1 year earlier | $28.61M Ended 2024-12-31 | $5.04M Ended 2024-12-31 | $85.84M Ended 2025-06-30 | $213.2K Ended 2024-10-31 |
| 2 years earlier | $32.05M Ended 2023-12-31 | $4.45M Ended 2023-12-31 | $85.88M Ended 2024-06-30 | n/a |
| 3 years earlier | $24.04M Ended 2022-12-31 | $7.42M Ended 2022-12-31 | $128.51M Ended 2023-06-30 | n/a |
| 4 years earlier | $401.2K Ended 2021-12-31 | $6.78M Ended 2021-12-31 | $108.93M Ended 2022-06-30 | n/a |